ReviewRheumatology international2020

Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes.

Efstathios Kastritis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.